BridgeBio Pharma Inc (BBIO)
28.53
+0.76
(+2.74%)
USD |
NASDAQ |
Dec 24, 16:00
BridgeBio Pharma Free Cash Flow: -456.32M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc | 8.227B |
| Alnylam Pharmaceuticals Inc | 16.06M |
| Cassava Sciences Inc | -78.07M |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Vertex Pharmaceuticals Inc | -1.352B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -180.57M |
| Cash from Investing (Quarterly) | 38.23M |
| Cash from Financing (Quarterly) | 0.707M |
| Free Cash Flow Per Share (Quarterly) | -0.967 |
| Free Cash Flow to Equity (Quarterly) | -184.02M |
| Free Cash Flow Yield | -8.77% |